Pharmaceuticals 2013, 6(2), 161-183; doi:10.3390/ph6020161
Review

Dendrimers for siRNA Delivery

Center for Pharmaceutical Biotechnology and Nanomedicine, 360 Huntington Ave, 140 The Fenway, Northeastern University, Boston, MA 02115, USA
* Author to whom correspondence should be addressed.
Received: 7 January 2013; in revised form: 17 January 2013 / Accepted: 29 January 2013 / Published: 4 February 2013
PDF Full-text Download PDF Full-Text [581 KB, uploaded 4 February 2013 11:07 CET]
Abstract: Since the discovery of the “starburst polymer”, later renamed as dendrimer, this class of polymers has gained considerable attention for numerous biomedical applications, due mainly to the unique characteristics of this macromolecule, including its monodispersity, uniformity, and the presence of numerous functionalizable terminal groups. In recent years, dendrimers have been studied extensively for their potential application as carriers for nucleic acid therapeutics, which utilize the cationic charge of the dendrimers for effective dendrimer-nucleic acid condensation. siRNA is considered a promising, versatile tool among various RNAi-based therapeutics, which can effectively regulate gene expression if delivered successfully inside the cells. This review reports on the advancements in the development of dendrimers as siRNA carriers.
Keywords: dendrimer; siRNA; delivery

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Biswas, S.; Torchilin, V.P. Dendrimers for siRNA Delivery. Pharmaceuticals 2013, 6, 161-183.

AMA Style

Biswas S, Torchilin VP. Dendrimers for siRNA Delivery. Pharmaceuticals. 2013; 6(2):161-183.

Chicago/Turabian Style

Biswas, Swati; Torchilin, Vladimir P. 2013. "Dendrimers for siRNA Delivery." Pharmaceuticals 6, no. 2: 161-183.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert